Cargando…
Phase II study of the thymidylate synthetase inhibitor CB3717 (N10-propargyl-5,8-dideazafolic acid) in colorectal cancer.
| Autores principales: | , , , , |
|---|---|
| Formato: | Texto |
| Lenguaje: | English |
| Publicado: |
Nature Publishing Group
1988
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2246458/ https://www.ncbi.nlm.nih.gov/pubmed/3408648 |
| _version_ | 1782150776045436928 |
|---|---|
| author | Harding, M. J. Cantwell, B. M. Milstead, R. A. Harris, A. L. Kaye, S. B. |
| author_facet | Harding, M. J. Cantwell, B. M. Milstead, R. A. Harris, A. L. Kaye, S. B. |
| author_sort | Harding, M. J. |
| collection | PubMed |
| description | |
| format | Text |
| id | pubmed-2246458 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 1988 |
| publisher | Nature Publishing Group |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-22464582009-09-10 Phase II study of the thymidylate synthetase inhibitor CB3717 (N10-propargyl-5,8-dideazafolic acid) in colorectal cancer. Harding, M. J. Cantwell, B. M. Milstead, R. A. Harris, A. L. Kaye, S. B. Br J Cancer Research Article Nature Publishing Group 1988-06 /pmc/articles/PMC2246458/ /pubmed/3408648 Text en https://creativecommons.org/licenses/by/4.0/This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit https://creativecommons.org/licenses/by/4.0/. |
| spellingShingle | Research Article Harding, M. J. Cantwell, B. M. Milstead, R. A. Harris, A. L. Kaye, S. B. Phase II study of the thymidylate synthetase inhibitor CB3717 (N10-propargyl-5,8-dideazafolic acid) in colorectal cancer. |
| title | Phase II study of the thymidylate synthetase inhibitor CB3717 (N10-propargyl-5,8-dideazafolic acid) in colorectal cancer. |
| title_full | Phase II study of the thymidylate synthetase inhibitor CB3717 (N10-propargyl-5,8-dideazafolic acid) in colorectal cancer. |
| title_fullStr | Phase II study of the thymidylate synthetase inhibitor CB3717 (N10-propargyl-5,8-dideazafolic acid) in colorectal cancer. |
| title_full_unstemmed | Phase II study of the thymidylate synthetase inhibitor CB3717 (N10-propargyl-5,8-dideazafolic acid) in colorectal cancer. |
| title_short | Phase II study of the thymidylate synthetase inhibitor CB3717 (N10-propargyl-5,8-dideazafolic acid) in colorectal cancer. |
| title_sort | phase ii study of the thymidylate synthetase inhibitor cb3717 (n10-propargyl-5,8-dideazafolic acid) in colorectal cancer. |
| topic | Research Article |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2246458/ https://www.ncbi.nlm.nih.gov/pubmed/3408648 |
| work_keys_str_mv | AT hardingmj phaseiistudyofthethymidylatesynthetaseinhibitorcb3717n10propargyl58dideazafolicacidincolorectalcancer AT cantwellbm phaseiistudyofthethymidylatesynthetaseinhibitorcb3717n10propargyl58dideazafolicacidincolorectalcancer AT milsteadra phaseiistudyofthethymidylatesynthetaseinhibitorcb3717n10propargyl58dideazafolicacidincolorectalcancer AT harrisal phaseiistudyofthethymidylatesynthetaseinhibitorcb3717n10propargyl58dideazafolicacidincolorectalcancer AT kayesb phaseiistudyofthethymidylatesynthetaseinhibitorcb3717n10propargyl58dideazafolicacidincolorectalcancer |